Showing results (91-100 of 110) with videos related to
Sort By:
Pageof 11
ESMO Open|January 22, 2025
Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real worldE Blondeaux, L Boni, G Chilà, et al.Surgery|November 18, 2005
Obese teenagers treated by Lap-Band System: the Italian experienceL Angrisani, F Favretti, F Furbetta, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancerE Vrdoljak, N Marschner, C Zielinski, et al.Scientific Reports|February 8, 2020
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signalingA Romano, N L Parrinello, V Simeon, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2018
Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trialL Malorni, G Curigliano, A M Minisini, et al.Obesity Surgery|July 4, 2001
Laparoscopic Italian experience with the Lap-BandL Angrisani, M Alkilani, N Basso, et al.Surgical Endoscopy|November 29, 2002
Lap Band adjustable gastric banding system: the Italian experience with 1863 patients operated on 6 yearsL Angrisani, F Furbetta, S B Doldi, et al.ESMO Open|August 9, 2024
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trialF Poggio, E Blondeaux, M Tagliamento, et al.ESMO Open|April 5, 2021
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational studyF Schettini, B Conte, G Buono, et al.Obesity Surgery|February 6, 2003
Results of the Italian multicenter study on 239 super-obese patients treated by adjustable gastric bandingL Angrisani, F Furbetta, S B Doldi, et al.Pageof 11